XML 49 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders’ Equity (Deficit) (Details) - USD ($)
 1 Months Ended 12 Months Ended
Oct. 06, 2020
Jun. 29, 2020
Oct. 31, 2017
Dec. 31, 2020
Dec. 31, 2019
Sep. 10, 2020
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Common stock, shares authorized       27,000,000 27,000,000  
Common stock, par value (in Dollars per share)       $ 0.001 $ 0.001  
Common stock issued       874,916   2,400,000
Stock compensation for consulting services (in Dollars)       $ 2,477,434    
Shares issued for intangible assets       150,000    
Intangible assets valued (in Dollars)       $ 320,850    
Issue of common stock       4,297,703    
Exercise of warrants and received (in Dollars)       $ 210,544  
Common stock issued for preferred shares       1,250,000    
Settlement of accounts payable Shares       146,818    
Settlement of debt       62,500    
Common stock issued for service         41,000  
Common stock for services and recognized expense (in Dollars)       $ 2,477,434 $ 82,000  
Reverse stock split, description   On June 29, 2020, the Company effectuated a 1-for-2 reverse stock split of its issued and outstanding shares of common stock by filing a certificate of amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware.        
Preferred stock, shares authorized       3,000,000 3,000,000  
Preferred stock, par value (in Dollars per share)       $ 0.001 $ 0.001  
Granted stock options       880,500 700,000  
Exercise prices (in Dollars per share)       $ 1.94    
Total grant fair value (in Dollars)         $ 2,495,556  
Stock option exercise price (in Dollars per share)         $ 4.00  
Compensation expense (in Dollars)       $ 406,880    
Share based payment remaining expenses (in Dollars)       $ 1,781,485    
Weighted average vesting term       2 years 146 days    
Compensation expense related to options issued and vesting (in Dollars)         $ 2,513,826  
Issue of aggregate stock option 40,000          
Warrant issued       60,000    
Warrant exercise price (in Dollars per share)       $ 5.00    
Stock option [member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Total grant fair value (in Dollars)       $ 1,668,997    
Minimum [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Exercise prices (in Dollars per share)       $ 1.92    
Maximum [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Exercise prices (in Dollars per share)       $ 11.00    
Warrant [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Share based payment remaining expenses (in Dollars)       $ 294,948    
Warrants issued and vesting (in Dollars)       $ 304,526 $ 1,102,596  
Weighted average vesting term       328 days    
Warrants exercised       4,297,703    
Shares of common stock       4,298,903    
Proceeds from exercised (in Dollars)       $ 210,544    
2017 Equity Incentive Plan [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Share issued for stock based compensation     2,500,000      
IPO [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Stock issued       1,226,668    
September 2020 Offering [Member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Stock issued       1,150,000    
Series A Preferred Stock [Member] | Stock option [member]            
Stockholders’ Equity (Deficit) (Details) [Line Items]            
Preferred stock shares       1,250,000